Last reviewed · How we verify
Umbilical Cord Serum eye drops
At a glance
| Generic name | Umbilical Cord Serum eye drops |
|---|---|
| Sponsor | National University of Malaysia |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Umbilical Cord Serum Versus Conventional Eyedrops (PHASE1, PHASE2)
- Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy (NA)
- Cord Blood Serum in the Treatment of Ocular Surface Diseases
- The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy (PHASE1)
- Umbilical Cord Serum Eye Drops (NA)
- Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Umbilical Cord Serum eye drops CI brief — competitive landscape report
- Umbilical Cord Serum eye drops updates RSS · CI watch RSS
- National University of Malaysia portfolio CI